In a recent announcement, National Institutes of Health director Jay Bhattacharya’s appointment has stirred up controversy as his actions seem to contradict his stated focus on vulnerable populations and racial health disparities. Bhattacharya, who previously served as a professor of health policy at Stanford University, has published several papers on racial health disparities and has emphasized the importance of supporting research that benefits minority populations.
However, despite his public support for vulnerable communities, Bhattacharya’s tenure has been marked by the termination of grants for health disparities research, including a $750,000 grant awarded to Duke University hematologist Charity Oyedeji. Oyedeji’s research aimed to assess and prevent disability in individuals with sickle cell disease, a condition that disproportionately affects Black Americans. The termination of her grant was justified by the NIH citing concerns that diversity, equity, and inclusion studies could potentially lead to unlawful discrimination based on race.
This decision has raised questions about whether Bhattacharya is truly committed to supporting research that benefits minority populations or if his actions are in line with the Trump administration’s attack on diversity, equity, and inclusion initiatives. Despite claims to the contrary, Bhattacharya has been unable to prevent the termination of grants for health disparities research, leading to confusion within the agency and confrontations with staff members.
Internal memos, recordings of NIH town hall meetings, and court records reviewed by STAT, as well as interviews with current and former NIH employees, paint a picture of tension and confusion within the agency. In one particularly contentious meeting, an NIH employee directly challenged Bhattacharya’s understanding of grant terminations at the agency, highlighting the disconnect between his words and actions.
The situation has escalated to the point where there have been scattered attempts to clarify the record, but the underlying issues remain unresolved. The dissonance between Bhattacharya’s public statements and the actions taken under his leadership has raised concerns about the future of health disparities research at the NIH and the agency’s commitment to supporting vulnerable populations.
